GURUFOCUS.COM » STOCK LIST » Europe » Germany » STU » EyePoint Pharmaceuticals Inc (STU:PV3) » Definitions » Net Interest Income (for Banks)
Switch to:

EyePoint Pharmaceuticals (STU:PV3) Net Interest Income (for Banks)

View and export this data going back to . Start your Free Trial

Net Interest Income only applies to banks.

EyePoint Pharmaceuticals (STU:PV3) Business Description

EyePoint Pharmaceuticals logo
Traded in Other Exchanges
480 Pleasant Street, Suite B300, Watertown, MA, USA, 02472
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.